American Portfolios Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$218K Buy
1,166
+2
+0.2% +$422 0.01% 988
2022
Q2
$189K Sell
1,164
-1,805
-61% -$285K 0.01% 1070
2022
Q1
$558K Sell
2,969
-1,360
-31% -$258K 0.02% 690
2021
Q4
$1.15M Buy
4,329
+1,783
+70% +$480K 0.04% 445
2021
Q3
$736K Buy
2,546
+2,297
+922% +$589K 0.03% 555
2021
Q2
$49.7K Sell
249
-3,323
-93% -$645K ﹤0.01% 1729
2021
Q1
$694K Sell
3,572
-239
-6% -$49K 0.03% 539
2020
Q4
$730K Buy
3,811
+1,557
+69% +$283K 0.04% 442
2020
Q3
$333K Sell
2,254
-1,085
-32% -$155K 0.02% 610
2020
Q2
$413K Buy
3,339
+526
+19% +$61.9K 0.03% 499
2020
Q1
$272K Buy
2,813
+2,732
+3,373% +$264K 0.02% 552
2019
Q4
$7.49K Hold
81
﹤0.01% 2115
2019
Q3
$6.21K Buy
+81
New +$7.08K ﹤0.01% 2109

Other funds holding RGEN

American Portfolios Advisors's RGEN Position: Q3 2022 in Review

American Portfolios Advisors increased its Repligen (RGEN) stake by 0.17% in Q3 2022, buying an estimated $422 and bringing the position to 1,166 shares worth $218K. The position accounts for 0.01% of the portfolio, ranked #988.

American Portfolios Advisors first reported a position in RGEN in Q3 2019 and has held it in 13 quarters since. The position peaked at $1.15M in Q4 2021. 434 funds tracked by Wall St. Rank hold RGEN as of Q3 2022.

  • American Portfolios Advisors held 1,166 shares of Repligen worth $218K as of Q3 2022.
  • American Portfolios Advisors bought 2 Repligen shares in Q3 2022, an estimated $422.
  • Repligen made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #988 holding.
  • American Portfolios Advisors first reported a position in Repligen in Q3 2019 and has held it in 13 quarters since.
  • American Portfolios Advisors's Repligen position peaked at $1.15M in Q4 2021.
  • 434 funds tracked by Wall St. Rank held Repligen as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.